Search for: "Parallel Productions, Inc." Results 601 - 620 of 1,004
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Aug 2010, 5:12 pm by Eric Schweibenz
More specifically, Thomson Licensing describes the accused products as liquid crystal display (LCD) devices manufactured and imported from China, including monitors, televisions, and modules and components thereof, including LCD panels, LCD controllers, and birefringent film. [read post]
4 Aug 2009, 6:41 am
You should use this citation whenever you cite the opinion, with a P.3d parallel citation. [read post]
7 Sep 2011, 4:22 am by Marie Louise
Hsu) US wary of WIPO initiative to host meeting on avian influenza and intellectual property rights (2005) (KEI) Surprisingly excellent analysis of PhRMA’s 2009 Special 301 filing on Poland by US Embassy in Warsaw (KEI) Cable: US Government collaboration with drug companies to lobby the Finnish Parliament on drug pricing legislation (KEI) Wikileaks cables on the US opposition to Philippines legislation on affordable medicines (KEI) Implementing the Jordan FTA rules on exclusive rights in… [read post]
2 Sep 2009, 5:57 pm
: Jacobson v Celgene (Patent Baristas) Ultracet (Tramadol/Acetaminophen) – US: CAFC vacates Ultracet obviousness decision: Ortho-McNeil Pharmaceutical, Inc v Teva Pharmaceuticals (not precedential) (Patently-O) (Patent Docs) (SmartBrief) Viread (Tenofovir) – India: MSF announces Patent Office rejected patents on AIDS drugs Tenofovir and Darunavir (Intellectual Property Watch)   [read post]
25 Oct 2008, 12:03 am
Sandoz, Inc (Law360) (Hal Wegner) (Patently-O) (Patent Prospector) (PLI) Levaquin (Levofloxacin) - UK: Levofloxacin SPC valid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd & Anor (IPKat) (The SPC blog) Sustiva (Efavirenz) - Brazil: Compulsory licensed Efavirenz will be manufactured by public Brazilian laboratories by end of 2008 (IP tango)   General A patent question of patents: Prof T Pogge's 'Health Impact Fund' alternative licensing system (Patent… [read post]
10 Jun 2010, 1:54 pm by Bexis
Medtronic, Inc., 552 U.S. 312 (2008):  Lewkut v. [read post]
25 Mar 2011, 2:50 pm by Rebecca Tushnet
Many offline parallels, but online is just more obvious. [read post]
29 Mar 2020, 7:22 am by Fred Rocafort
In Part 5, we discussed how the coronavirus is giving nearly free license to foreign manufacturers to provide bad product, counterfeit product, or no product at all and this is especially true of the products most needed to fight against the virus: surgical masks, N95 masks, ventilators (really anything PPE), and cleaning products and how overseas product procurement and IP have never been at greater risk. [read post]
14 Dec 2009, 5:14 am
: Alcon Inc v Bausch & Lomb (Australia) Pty Ltd (ipwars) FCA: Infringing a registered design? [read post]
10 May 2019, 9:12 am by Eric Goldman
Franklin Mint, “The nominative fair use analysis is appropriate where a defendant has used the plaintiff’s mark to describe the plaintiff’s product, even if the defendant’s ultimate goal is to describe his own product. [read post]
17 Jun 2014, 8:45 am
Id. at 4-5, 7, 20-22.FDA PMA involves rigorous review of the adequacy of product labeling/warnings. [read post]
22 Mar 2011, 5:48 am by Steve McConnell
Smart Balance, Inc., CV 10-00927 (C.D. [read post]